Clinical trial
Effect of a Single Dose Infusion of Dexmedetomidine in Reducing Incidence of Emergence Agitation After Nasal Surgery - a Randomised Contolled Trial
NCT05634148 is registered in ClinicalTrials.gov with Security Forces Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of a Single Dose Infusion of Dexmedetomidine in Reducing Incidence of Emergence Agitation After Nasal Surgery - a Randomised Contolled Trial
- Lead sponsor
- Security Forces Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 22, 2022
- Completion date
- April 1, 2023
- Enrollment
- 42 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
postoperative delirium